Effect of Diclofenac with B Vitamins on the Treatment of Acute Pain Originated by Lower-Limb Fracture and Surgery by Ponce-Monter, Héctor A. et al.
Hindawi Publishing Corporation
Pain Research and Treatment
Volume 2012, Article ID 104782, 5 pages
doi:10.1155/2012/104782
Clinical Study
Effectof Diclofenac with B Vitamins on the Treatment of
Acute Pain Originated by Lower-Limb Fracture and Surgery
H´ ector A. Ponce-Monter,1 Mario I. Ortiz,1,2 AlexisF. Garza-Hern´ andez,2
Ra´ ulMonroy-Maya,3 MariselaSoto-R´ ıos,3 LourdesCarrillo-Alarc´ on,1,4
GerardoReyes-Garc´ ıa,5 andEduardoFern´ andez-Mart´ ınez1
1 ´ Area Acad´ emica de Medicina del Instituto de Ciencias de la Salud, Universidad Aut´ onoma del Estado de Hidalgo,
42090 Pachuca, HGO, Mexico
2Research and Traumatology Departments, Hospital del Ni˜ no DIF, 42090 Pachuca, HGO, Mexico
3Hospital General de los Servicios de Salud del Estado de Hidalgo, 42090 Pachuca, HGO, Mexico
4SubDirecci´ on de Investigaci´ on de los Servicio de Salud de Hidalgo, 42030 Pachuca, HGO, Mexico
5Secci´ on de Estudios de Posgrado e Investigaci´ on, Escuela Superior de Medicina, IPN, 11340, DF, Mexico
Correspondence should be addressed to H´ ector A. Ponce-Monter, hecpon43@yahoo.com.mx
Received 11 August 2011; Revised 22 September 2011; Accepted 27 September 2011
Academic Editor: Mar´ ıa Asunci´ on Romero Molina
Copyright © 2012 H´ ector A. Ponce-Monter et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
The aim of this study was to compare the eﬃcacy of diclofenac, for the treatment of acute pain originated by lower-limb fracture
and surgery, with that of diclofenac plus B vitamins. This was a single-center, prospective, randomized, and double-blinded clin-
ical trial. Patients with lower-limb closed fractures rated their pain on a 10cm visual analog scale (VAS). Patients were then ran-
domized to receive diclofenac or diclofenac plus B vitamins (thiamine, pyridoxine, and cyanocobalamin) intramuscularly twice
daily. Patient evaluations of pain intensity were recorded throughout two periods: twenty-four hours presurgery and twenty-
four hours postsurgical. One hundred twenty-two patients completed the study. The subjects’ assessments of limb pain on the VAS
showedasigniﬁcantreductionfrombaselinevaluesregardlessofthetreatmentgroup.DiclofenacplusBvitaminscombinationwas
more eﬀective to reduce the pain than diclofenac alone. The results showed that the addition of B vitamins to diclofenac increased
its analgesic eﬀect. The novelty of this paper consists in that diclofenac and diclofenac plus B vitamins were useful for treatment of
acute pain originated by lower-limb fracture and surgery.
1.Introduction
Anumberofsituationsarepronetodeveloppainsymptoma-
tology, such as tissue degeneration, infection, inﬂammation,
cancer, trauma, surgery, and limb fractures. Each of these
physiological abnormalities requires a therapeutic approach
diﬀerent from the last. In acute pain, caused by fracture and/
or surgery, several classes of analgesics have been utilized.
Thesebasicremediesforanalgesia,however,arestillconﬁned
to a small number of medications, including nonsteroidal
anti-inﬂammatory drugs (NSAIDs), local anesthetics, and
opioids. In addition, most of these drugs have side eﬀects,
limiting their use in clinical practice [1, 2].
The clinical use of combinations of analgesic agents has
increased signiﬁcantly in the last few years. The purpose is
to associate two or more drugs with diﬀerent mechanisms of
action, in hopes of achieving a synergistic interaction that
yields a suﬃcient analgesic eﬀect with low doses of each
agent, therefore, reducing the intensity and incidence of un-
toward eﬀects [3].
B vitamins are a water-soluble group of vitamins includ-
ingthiamine,riboﬂavin,niacinandniacinamide,pyridoxine,
cobalamin, folic acid, pantothenic acid, biotin, choline,
inositol, and para-aminobenzoic acid (PABA). In particular,
some of these B vitamins (thiamine, pyridoxine and cyan-
ocobalamin) have been used, not only in the treatment of
pain and inﬂammation resulting from vitamin deﬁciency
but also alone or in combination with diclofenac or
other NSAIDs for various painful diseases such as poly-
neuropathies, degenerative diseases of the spinal column,2 Pain Research and Treatment
rheumaticdiseaseslumbagoandpainoriginatedfromtonsil-
lectomy [4–8]. However, most clinical studies have evaluated
this combination in neuropathic pain [4–6, 8]. Recently, a
study demonstrated the utility of the diclofenac-B vitamins
combination in the pain originating from tonsillectomy
surgery [7]. Nevertheless, the sample size of this last study
was too small to be representative and the administration
route was the intravenous via. On the other hand, this di-
clofenac-B vitamins combination has never been tested in
the acute pain produced by fracture or other kind of surgical
procedures. Therefore, the main objective of the present
clinical study was to compare the eﬃcacy and tolerability of
diclofenac for treatment of acute pain following lower-limb
fracture and surgery, with that of diclofenac in combina-
tion with B vitamins (thiamine, pyridoxine, and cyanocobal-
amin). Indeed, we previously conducted a pilot study with
14 patients, with the aim of establishing the adequate exper-
imental conditions as well as to calculate the appropriate
sample size, wherein both treatments were equally eﬀective
in reducing pain [9].
2.MaterialsandMethods
This was a single-center, prospective, randomized and dou-
ble-blinded clinical trial. The study was carried out at the
Hospital General SSH Pachuca, Hidalgo, Mexico from Jan-
uary 2008 to February 2010. The study protocol was ap-
proved by the Ethic and Investigation Committees from the
Hospital General SSH Pachuca, Hidalgo, Mexico as well as
this was conducted according to the Declaration of Helsinki.
The participants of the study were patients with lower-
limbclosedfractures,ranginginagefrom18to55years,with
acute pain ≥5cm according to a 10cm visual analog scale
(VAS; 0 = no pain and 10 = the worst pain), good health
determined by clinical history and laboratory studies, with-
out sanguineous dyscrasias or hypersensitivity to drugs to be
employed, and who consented to participate voluntarily.
After giving their consent, patients rated their pain on
a VAS, and they were then randomized into one of two
groups receiving 75mg diclofenac or 75mg diclofenac plus B
vitamins (thiamine: 100mg, pyridoxine: 100mg, and cyano-
cobalamin: 1mg) twice daily (all intramuscularly). Patient
evaluations of pain intensity were recorded throughout two
periods: twenty-four hours presurgical and twenty-four
hourspostsurgical.Twenty-fourhoursaftertheﬁrstdrugad-
ministration, patients underwent elective lower-limb sur-
gery. Standardized general anesthetic techniques were used
for all patients. Patients received 50mg ranitidine intra-
venouslytwiceadaythroughoutthestudy.Ifthepainwasnot
controlledaftertwohours,patientsreceivedrescuetreatment
with morphine. At the end of the study, the improvement in
pain levels was evaluated by a Likert scale. The categorical
Likert response alternatives consisted of four descriptions.
Responses were rated 0–3: 0 = complete relief, 1 = moderate
relief, 2 = slight relief, 3 = without relief. Gastrointestinal
sideeﬀects,rash,orspontaneouscomplaintsofotheradverse
eﬀects such as postsurgical bleeding problems during the
postoperative phase were registered.
Data are shown as the mean ± SEM. Data were evaluated
using t student and a nonparametric statistical analysis, the
Mann-Whitney U test. P<0.05 was required for signiﬁ-
cance.
3. Results
One hundred twenty-two patients completed the study,
sixty-twointhediclofenacgroup(forty-twomaleandtwenty
female) and sixty in the diclofenac with B vitamins group
(twenty-seven male and thirty-three female). The mean ±
standard deviation age in the diclofenac group was 37.9 ±
10.5y e a r sa n d3 5 .0 ± 8.8 years in the diclofenac plus B vita-
mins group, which does not represent a signiﬁcant diﬀerence
between the groups (P>0.05).
In the study presented here, all patients received medi-
cation for forty-eight hours and the acute pain induced by
lower-limb fracture and surgery was monitored and record-
ed. The lower-limb fractures that the patients presented
with were 8 fractures of the patella, 47 ankle fractures, 24
tibia shaft fractures, 14 tibial plateau fractures, 20 diaphyseal
fractures of the femur, 6 subtrochanteric femoral fractures, 2
fractures of the calcaneus, and 1 fracture of the talus. There
was no statistically signiﬁcant diﬀerence in the type of
fracture and gender between the two treatment groups
(P>0.05).
The subjects’ assessment of limb pain on the VAS in both
treatments showed a signiﬁcant reduction from baseline at
4, 8, 12, 24, 36, and 48 hours after treatment. Diclofenac
plus B vitamins was more eﬀective to reduce the pain than
diclofenac alone at 8, 12, 24, 36, and 48 hours after treatment
(P<0.05) (Figure 1). However, diclofenac was more suc-
cessful to decrease the pain than diclofenac plus B vitamins
at 4 hours after treatment (P<0.05) (Figure 1). The value
in the Likert scale of the diclofenac plus B vitamins group
was 1.37 ± 0.5 with this value being statistically diﬀerent at
the value of 1.56±0.5 for the diclofenac group. No statistical
diﬀerence was found when comparing the groups according
t og e n d e ra n dt y p eo ff r a c t u r e( P>0.05).
Rescue treatments were not applied. All the patients re-
ported pain in the administration site, but generally speak-
ing, all the regimens were well tolerated. None of the patients
had any bleeding complication or gastrointestinal complain
before or after surgery.
4. Discussion
Fractures of the lower limb are common, especially in the
elderly, and are often associated with considerable morbidity
and lengthy hospitalization. The immediate goal of treating
acute lower-limb fractures is to decrease pain and swelling as
well as to protect adjacent structures from further injury. For
this reason, after immobilization of the lower limb, NSAIDs
are invaluable in treating these musculoskeletal conditions,
primarily due to their analgesic and anti-inﬂammatory ef-
fects. Unfortunately, NSAIDs propensity to cause gastroin-
testinal damage and patient discomfort limits their use. It is
known that as many as two to four percent of patients who
take NSAIDs during long-term therapy may have seriousPain Research and Treatment 3
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Figure 1: Time course of the eﬀect of diclofenac alone or diclofenac
plus B vitamins for the treatment of pain produced by lower-limb
fracture and surgery. The points represent the average ± standard
error of the media values of the visual analogous scale (VAS)
evaluatedatdiﬀerenthours. ∗Signiﬁcantlydiﬀerentfromdiclofenac
group (P<0.05). #Signiﬁcantly diﬀerent from diclofenac + B vita-
mins group (P<0.05).
gastrointestinal side eﬀects such as perforation, ulceration,
or bleeding [10, 11]. An eﬀective strategy to decrease the
occurrence of these adverse eﬀects is to combine an NSAID
with two or more analgesics, each one with diﬀerent mech-
anisms of action. The synergistic outcome achieved yields a
suﬃcient analgesic eﬀect with relatively low doses, reducing
the intensity and incidence of untoward eﬀects accordingly
[3]. In this regard, it has been demonstrated that the com-
bination of diclofenac and B vitamins is eﬀective in relieving
neuropathic pain [4, 5, 8]. Likewise, it is possible to reduce
the diclofenac dosage and/or the duration of the treatment
[4–6, 8]. A recent study showed that diclofenac plus B vita-
mins were not superior to diclofenac alone in the treatment
of pain originated from tonsillectomy [7]. However, in this
same study, the total dose of diclofenac was 45% less in
the diclofenac plus B vitamins group suggesting a potential
beneﬁttothisapproachtoanalgesictherapy.Inamorerecent
r e p o r t ,i tw a sd e m o n s t r a t e dt h a ta f t e r3d a y so ft r e a t m e n t ,
a statistically signiﬁcant higher proportion of subjects with
lumbago who received diclofenac plus B vitamins completed
the study due to the treatment success compared with pa-
tients that received diclofenac alone [8]. Furthermore, the
combination therapy yielded superior results in pain reduc-
tion, improvement of mobility and functionality [8].
In the present study, both diclofenac and diclofenac plus
Bvitaminswereabletoproduceananalgesiceﬀectinpatients
with acute pain originating from lower-limb fracture and
surgery. Likewise, at certain points of time the diclofenac-
B vitamins combination provided a signiﬁcantly greater ana-
lgesia than the single-agent diclofenac. In this last case, B vit-
amins potentiated the analgesia produced by diclofenac.
There is evidences that B vitamins in their separate forms
(B1, B6, and B12) have antinociceptive or analgesic eﬀects.
In this regard, in animal experiments, thiamine (B1 vitamin)
was able to produce antinociception in the model of pain
induced by acetic acid in mice, in the second phase of the
formalin test in mice and in the model of pain induced by
electricalstimulationofaﬀerentﬁbers[12,13].Clinicalstud-
ies showed that administration of a derivative of thiamine,
benfothiamine, caused a signiﬁcant improvement in patients
with alcoholic polyneuropathy and in patients with diabetic
neuropathy[14,15].Ontheotherhand,pyridoxine(B6vita-
min) produced antinociception during the formalin test in
mice and in the model of acetic acid in mice [12]. Clinical
assays revealed that administration of pyridoxine improves
symptoms that occur in the carpal tunnel syndrome and
peripheral polyneuropathy [16, 17]. Finally, a clinical study
demonstrated that systemic administration of cyanocobal-
amin (vitamin B12) to patients with low back pain was able
to produce a signiﬁcant decrease in pain and also decreased
theconsumptionofacetaminophenasadjuvanttherapy[18].
However, with the present experimental design it is im-
possible to know which B vitamin is the responsible of the
better analgesia.
The increased analgesia with the diclofenac-B vitamins
combination diﬀers from the similar analgesic eﬀects ob-
served with diclofenac alone and diclofenac plus B vitamins
in the treatment of acute postoperative pain after tonsillec-
tomy [7]; probably, such a diﬀerence was due to the diﬀerent
kindofacutepainandthedissimilaradministrationpathway,
since we used the intramuscular administration, while in
that study the authors used intravenous infusion over a 12h
period [7]. To our knowledge, in our country there is no the
pharmaceutical form of B vitamins for intravenous admin-
istration; there are only presentations for oral and intra-
muscular administration. A dosage form for intravenous ad-
ministration would be very useful in cases where it cannot be
usedorally(e.g.,inunconsciouspatients)orintramuscularly.
Diclofenac is an NSAID that exhibits potent analgesic
and anti-inﬂammatory properties. It is known that diclo-
fenac as well as other nonselective NSAIDs are able to impair
prostaglandin synthesis by inhibiting the cyclooxygenase
isozymes COX-1 and COX-2 in injured tissues and in the
central nervous system. However, there is also evidence that
diclofenac exhibits additional prostaglandin-independent
propertiesthatmediateitsantinociceptiveeﬀects.Forinstan-
ce, diclofenac is able to inhibit H+-gated channels in sensory
neurons, increase the concentration of kynurenate (an
endogenous antagonist of NMDA receptors), stimulate the
nitric oxide-cGMP-K+ channels pathway, and activate met-
formin- and phenformin-dependent mechanisms to induce
antinociception [19–23]. On the other hand, several studies
demonstrated antinociceptive and antihyperalgesic eﬀects
with the mixture of thiamine, pyridoxine, and cyanocobal-
amin in the models of hyperalgesia induced by carrageenan,
in the pressure testing of the tail, and in the formalin model
[24, 25]. Regarding the action mechanisms by which B vit-
amins produce their eﬀects, it has been suggested that these
result from the activation of several systems. For example,
pyridoxine alone or in combination with thiamine and cya-
nocobalamin was able to increase the synthesis and secretion
of serotonin in various brain regions [26, 27]. Furthermore,
the analgesic eﬀects of B vitamins have been associated with
an increase in inhibitory control of aﬀerent nociceptive neu-
rons in the spinal cord [28] and reduced the response of tha-
lamicneuronstonociceptivestimulation[29].Morerecently,4 Pain Research and Treatment
it was conﬁrmed that the analgesic eﬀects induced by B vit-
amins were partially blocked by naloxone, suggesting that B
vitamins could release endogenous opioids that could acti-
vate opioid receptors [25]. Besides, there is experimental
evidence suggesting that the eﬀects induced by the combi-
nation of B vitamins involve the nitric oxide-cGMP system
[30, 31]. However, other mechanisms have been proposed,
for example, it has been shown that pyridoxine is capable of
blocking the synthesis of prostaglandin E2 in humans [32].
In light of this evidence, it is possible to suggest that several
mechanisms could be implicated in the diclofenac-B vita-
minscombinationtoobtainamajoranalgesiaincomparison
with the analgesia by diclofenac alone. The real mechanisms
involvedinthepotentiationforthecombinationawaitfuture
elucidation.
Patients often experience unpredictable therapeutic and
diagnostic procedural-related pain in emergency rooms that
can be associated with considerable stress and anxiety [33].
Although procedural pain may be reduced by a variety of
psychological and pharmacological interventions [33], most
of these are not given in all the nonelective settings. For exa-
mple, in our study, after the intramuscular injection all the
patients reported pain at the administration site; however,
the characteristics of this pain were not evaluated or re-
corded.
One weakness of our study was that participants had dif-
ferent types of lower-limb fractures and surgeries, and this
diversity could have aﬀected the results in favor of providing
a better analgesic eﬀect with the combination of diclofenac
with B vitamins. However, it was noted that although the
patients had diﬀerent types of fractures, there was no sta-
tistically signiﬁcant diﬀerence in the level of pain that both
groups of patients presented with on their admission. There-
fore,itisnecessarytoevaluatetheeﬀectivenessofthiscombi-
nationinaparticulartypeoffractureorsurgery ,eithermem-
ber.
In conclusion, the present study gives evidence that the
combination of diclofenac plus B vitamins could be a safe
andinexpensivepostsurgicalanalgesicstrategy.Likewise,itis
necessary to undertake controlled studies using this combi-
nationindiﬀerentstatesofacutepostsurgicalpaintodemon-
strate its security and eﬃcacy.
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